Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity

• Autors principals: Pushpendra Goswami (Autor), Esther N. Oliva (Autor), Tatyana Ionova (Autor), Roger Else (Autor), Jonathan Kell (Autor), Adele K. Fielding (Autor), Daniel M. Jennings (Autor), Marina Karakantza (Autor), Saad Al-Ismail (Autor), Graham P. Collins (Autor), Stewart McConnell (Autor), Catherine Langton (Autor), Sam Salek (Autor)
• Format: Llibre
• Publicat: Frontiers Media S.A., 2020-03-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

BackgroundThe quality of life of patients at all stages of hematological malignancy is greatly affected by the disease and its treatment. There is a wide range of health-related quality of life (HRQoL) issues important to these patients. Any new instrument developed to measure HRQoL of such patients...